个性化糖尿病管理：从算法化治疗向个体化治疗转变
Personalized Diabetes Management: Moving from Algorithmic to Individualized Therapy.
作者信息
Subramanian Savitha, Hirsch Irl B
出版信息
Diabetes Spectr. 2014 May;27(2):87-91. doi: 10.2337/diaspect.27.2.87.
Abstract
Management of individuals with type 2 diabetes involves complex decision-making to attain good glycemic control. A personalized approach to the care of these individuals provides a unique management plan for each patient. This article reviews some of the important variables that require consideration for management of individuals with type 2 diabetes. We also provide a scoring scale to help clinicians make appropriate decisions regarding A1C targets while caring for these patients.
摘要
2型糖尿病患者的管理涉及复杂的决策过程，以实现良好的血糖控制。针对这些患者的个性化护理方法为每位患者提供了独特的管理计划。本文回顾了2型糖尿病患者管理中一些需要考虑的重要变量。我们还提供了一个评分量表，以帮助临床医生在照顾这些患者时就糖化血红蛋白（A1C）目标做出适当决策。
相似文献
1
Personalized Diabetes Management: Moving from Algorithmic to Individualized Therapy.个性化糖尿病管理：从算法化治疗向个体化治疗转变
Diabetes Spectr. 2014 May;27(2):87-91. doi: 10.2337/diaspect.27.2.87.
2
[Decision Cycle for Patient-Centered Glycemic Management in Type 2 Diabetes].
Hu Li Za Zhi. 2019 Dec;66(6):5-12. doi: 10.6224/JN.201912_66(6).02.
3
Managing type 2 diabetes: going beyond glycemic control.管理2型糖尿病：超越血糖控制
J Manag Care Pharm. 2008 Jun;14(5 Suppl B):s2-19.
4
An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment.一种基于循证医学的糖尿病降糖治疗方法以避免过度治疗。
Circulation. 2017 Jan 10;135(2):180-195. doi: 10.1161/CIRCULATIONAHA.116.022622.
5
Individualized glycaemic targets and pharmacotherapy in type 2 diabetes.个体化血糖目标与 2 型糖尿病的药物治疗。
Diab Vasc Dis Res. 2013 Sep;10(5):397-409. doi: 10.1177/1479164113490765. Epub 2013 May 27.
6
Evaluating a Glucose-Sensor-Based Tool to Help Clinicians and Adults With Type 1 Diabetes Improve Self-Management Skills.评估一种基于葡萄糖传感器的工具，以帮助临床医生和1型糖尿病成年人提高自我管理技能。
J Diabetes Sci Technol. 2018 Nov;12(6):1143-1151. doi: 10.1177/1932296818791534. Epub 2018 Jul 31.
7
Personalized Management of Type 2 Diabetes.2 型糖尿病的个体化管理。
Curr Diab Rep. 2019 Nov 4;19(11):115. doi: 10.1007/s11892-019-1244-0.
8
Shared decision-making in the care of individuals with diabetes.糖尿病患者护理中的共同决策。
Diabet Med. 2016 Jun;33(6):742-51. doi: 10.1111/dme.13143.
9
Identifying barriers to glycemic control in patients with type 2 diabetes after completion of an accredited education program.
J Am Pharm Assoc (2003). 2017 May-Jun;57(3S):S211-S216. doi: 10.1016/j.japh.2017.02.008. Epub 2017 Mar 31.
10
Optimizing combination therapy for type 2 diabetes in adolescents and adults: a case-based approach.优化青少年和成人2型糖尿病的联合治疗：基于病例的方法。
J Fam Pract. 2004 Oct;53(10):815-22.
引用本文的文献
1
A drug mix and dose decision algorithm for individualized type 2 diabetes management.一种用于个体化2型糖尿病管理的药物组合与剂量决策算法。
NPJ Digit Med. 2024 Sep 17;7(1):254. doi: 10.1038/s41746-024-01230-5.
2
Personalized Diabetes Management with Digital Twins: A Patient-Centric Knowledge Graph Approach.基于数字孪生的个性化糖尿病管理：一种以患者为中心的知识图谱方法。
J Pers Med. 2024 Mar 28;14(4):359. doi: 10.3390/jpm14040359.
3
Managing Diabetes Using Mobiab: Long-Term Case Study of the Impact of a Mobile App on Self-management.使用Mobiab管理糖尿病：一款移动应用对自我管理影响的长期案例研究
JMIR Diabetes. 2022 Apr 20;7(2):e36675. doi: 10.2196/36675.
4
Precision Health Care Elements, Definitions, and Strategies for Patients with Diabetes: A Literature Review.精准医疗保健要素、定义和糖尿病患者策略：文献综述。
Int J Environ Res Public Health. 2021 Jun 17;18(12):6535. doi: 10.3390/ijerph18126535.
5
The Influence of Baseline Hemoglobin A1c on Digital Health Coaching Outcomes in Adults With Type 2 Diabetes: Real-World Retrospective Cohort Study.基线糖化血红蛋白对2型糖尿病成人数字健康指导结果的影响：真实世界回顾性队列研究
JMIR Diabetes. 2021 Jun 16;6(2):e24981. doi: 10.2196/24981.
6
A Narrative Review of the Patient Journey Through the Lens of Non-communicable Diseases in Low- and Middle-Income Countries.从低收入和中等收入国家的非传染性疾病角度出发对患者就医旅程的叙述性回顾
Adv Ther. 2020 Dec;37(12):4808-4830. doi: 10.1007/s12325-020-01519-3. Epub 2020 Oct 14.
7
Randomised controlled trial of pharmacist-led patient counselling in controlling hypoglycaemic attacks in older adults with type 2 diabetes mellitus (ROSE-ADAM): A study protocol of the SUGAR intervention.随机对照试验药师主导的患者咨询在控制老年 2 型糖尿病患者低血糖发作中的作用（ROSE-ADAM）：SUGAR 干预研究方案。
Res Social Adm Pharm. 2021 May;17(5):885-893. doi: 10.1016/j.sapharm.2020.07.012. Epub 2020 Jul 29.
8
Patients With Type 2 Diabetes Are Willing to Do More to Overcome Therapeutic Inertia: Results From a Double-Blind Survey.2型糖尿病患者愿意采取更多行动来克服治疗惰性：一项双盲调查的结果
Clin Diabetes. 2020 Jul;38(3):222-229. doi: 10.2337/cd19-0067.
9
New Paradigm of Personalized Glycemic Control Using Glucose Temporal Density Histograms.使用葡萄糖时间密度直方图的个性化血糖控制新范式。
J Diabetes Sci Technol. 2019 Jul;13(4):708-717. doi: 10.1177/1932296818821423. Epub 2019 Jan 8.
10
Personalizing Type 2 Diabetes Management: Use of a Patient-Centered Approach to Individualizing A1C Goals and Pharmacological Regimens.个性化2型糖尿病管理：采用以患者为中心的方法来个体化糖化血红蛋白目标和药物治疗方案。
Clin Diabetes. 2017 Dec;35(5):321-328. doi: 10.2337/cd17-0083.
本文引用的文献
1
'I call it the blame and shame disease': a qualitative study about perceptions of social stigma surrounding type 2 diabetes.“我称之为指责和羞耻病”：一项关于 2 型糖尿病相关社会污名化看法的定性研究。
BMJ Open. 2013 Nov 18;3(11):e003384. doi: 10.1136/bmjopen-2013-003384.
2
Individualized glycaemic targets and pharmacotherapy in type 2 diabetes.个体化血糖目标与 2 型糖尿病的药物治疗。
Diab Vasc Dis Res. 2013 Sep;10(5):397-409. doi: 10.1177/1479164113490765. Epub 2013 May 27.
3
Structured personal care of type 2 diabetes: a 19 year follow-up of the study Diabetes Care in General Practice (DCGP).2 型糖尿病的结构化个人护理：一般实践中的糖尿病护理（DCGP）研究的 19 年随访。
Diabetologia. 2013 Jun;56(6):1243-53. doi: 10.1007/s00125-013-2893-1. Epub 2013 Apr 3.
4
Using multiple measures of glycemia to support individualized diabetes management: recommendations for clinicians, patients, and payers.采用多种血糖指标来支持个体化糖尿病管理：为临床医生、患者和支付方提供的建议。
Diabetes Technol Ther. 2012 Nov;14(11):973-83; quiz 983. doi: 10.1089/dia.2012.0132. Epub 2012 Oct 15.
5
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2型糖尿病高血糖管理：以患者为中心的方法：美国糖尿病协会（ADA）和欧洲糖尿病研究协会（EASD）的立场声明
Diabetes Care. 2012 Jun;35(6):1364-79. doi: 10.2337/dc12-0413. Epub 2012 Apr 19.
6
Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus.识别、发病机制和治疗 2 型糖尿病患者不同阶段的肾病。
Mayo Clin Proc. 2011 May;86(5):444-56. doi: 10.4065/mcp.2010.0713.
7
Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials.个体化 2 型糖尿病的血糖目标：近期临床试验的意义。
Ann Intern Med. 2011 Apr 19;154(8):554-9. doi: 10.7326/0003-4819-154-8-201104190-00007.
8
Patient adherence to medication requirements for therapy of type 2 diabetes.患者对 2 型糖尿病治疗药物要求的依从性。
Int J Clin Pract. 2011 Mar;65(3):314-22. doi: 10.1111/j.1742-1241.2010.02544.x.
9
Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis.2 型糖尿病作为抑郁症发病的危险因素：系统评价和荟萃分析。
Diabetologia. 2010 Dec;53(12):2480-6. doi: 10.1007/s00125-010-1874-x. Epub 2010 Aug 14.
10
The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach.2 型糖尿病血糖管理的 A1C 和 ABCD：医生的个性化方法。
Diabetes Metab Res Rev. 2010 May;26(4):239-44. doi: 10.1002/dmrr.1092.
Zotero 插件